By Administrator_India Capital Sands In a significant development, Johnson & Johnson on Monday (October 12) announced that it had temporarily halted the trial of its coronavirus COVID-19 vaccine after one of its participants fell ill. “We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, includingContinue Reading